Amplio Pharma is a startup based in the Netherlands, most recent round Seed, 2 tracked investors.
Amplio Pharma is a startup based in the Netherlands. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
Amplio Pharma develops modified retention technology to enhance the efficacy and safety of existing drugs, particularly focusing on improving the treatment of autoimmune diseases like rheumatoid arthritis through its NovoBioJect product.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.